Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev. peru. med. exp. salud publica ; 39(4): [450-455], oct. 2022. tab, graf
Artigo em Espanhol | LILACS | ID: biblio-1424345

RESUMO

El objetivo de este estudio fue determinar la presencia del Virus Papiloma Humano (VPH) tipo 16 y 18 en biopsias de tejido mamario parafinado de pacientes con diagnóstico clínico de cáncer de mama. Se analizaron 32 biopsias de cáncer de mama embebidas en parafina para detectar el ADN de VPH mediante PCR en tiempo real, los iniciadores estuvieron dirigidos al gen E6. Se evaluaron el tipo histológico, grado histológico y la sobreexpresión de C-erB2 y Ki-67 mediante inmunohistoquímica. El 84,38% (27) fueron positivos para VPH, el 25% (8) fueron positivos para VPH-16 y el 59,38% (19) para VPH-18. El 15,63% (5) de las muestras presentaron infección mixta. Se evidenció la sobrexpresión de C-erbB2 y Ki-67 en 6,25% (2) de las muestras positivas para VPH-16 y 15,63% (5) de las muestras positivas para VPH-18. Se detectó ADN de VPH-16 y VPH-18 en las muestras de biopsias analizadas mediante PCR en tiempo real.


The aim of this study was to determine the presence of Human Papillomavirus (HPV) type 16 and 18 in biopsies of paraffin-embedded breast tissue from patients with clinically diagnosed breast cancer. 32 paraffin-embedded breast cancer biopsies were analyzed in order to detect HPV DNA by real-time PCR, the primers were directed at the E6 gene. The histological type, histological grade and overexpression of C-erB2 and Ki-67 were evaluated by immunohistochemistry. 84.38% (27) of the samples were positive for HPV, 25% (8) were positive for HPV-16 and 59.38% (19) were positive for HPV-18. Mixed infection was found in 15.63% (5) of the samples. Overexpression of C-erbB2 and Ki-67 was seen in 6.25% (2) of the samples positive for HPV-16 and in 15.63% (5) samples positive for HPV-18. HPV-16 and HPV-18 DNA was detected in the biopsy samples analyzed by real-time PCR.


Assuntos
Humanos , Feminino , Neoplasias da Mama , Papillomavirus Humano 16 , Papillomavirus Humano 18 , Papillomaviridae , Tecidos , Biópsia , Imuno-Histoquímica , Diagnóstico Clínico , Reação em Cadeia da Polimerase
2.
Rev Peru Med Exp Salud Publica ; 39(4): 450-455, 2022.
Artigo em Espanhol, Inglês | MEDLINE | ID: mdl-36888807

RESUMO

OBJECTIVES.: Motivation for the study: there are few studies about high-risk Human Papillomavirus in patients with breast cancer, which is currently the most recurrent neoplasm in Peru. Main findings: greater presence of Human Papillomavirus was evidenced in infiltrating ductal carcinoma and grade III samples. In addition, real-time polymerase chain reaction showed greater diagnostic accuracy than immunohistochemistry. Implications: a better understanding of the presence of Human Papillomavirus and its possible relationship with breast cancer will contribute to improve preventive measures for this disease. The aim of this study was to determine the presence of Human Papillomavirus (HPV) type 16 and 18 in biopsies of paraffin-embedded breast tissue from patients with clinically diagnosed breast cancer. 32 paraffin-embedded breast cancer biopsies were analyzed in order to detect HPV DNA by real-time PCR, the primers were directed at the E6 gene. The histological type, histological grade and overexpression of C-erB2 and Ki-67 were evaluated by immunohistochemistry. 84.38% (27) of the samples were positive for HPV, 25% (8) were positive for HPV-16 and 59.38% (19) were positive for HPV-18. Mixed infection was found in 15.63% (5) of the samples. Overexpression of C-erbB2 and Ki-67 was seen in 6.25% (2) of the samples positive for HPV-16 and in 15.63% (5) samples positive for HPV-18. HPV-16 and HPV-18 DNA was detected in the biopsy samples analyzed by real-time PCR. MATERIALS AND METHODS.: Cross-sectional descriptive study with an analytical component, based on clinical records of patients at the Neurological Institute of Colombia, between 2013 and 2021. Progression to disability in MS patients was defined as the time to an increase of at least 0.5 points in the EDSS (Expanded Disability Status Scale) score, sustained for at least six months. A Cox regression model was used to estimate the survival function and Hazard Ratios (HR) with their 95% confidence intervals (95% CI).


OBJETIVOS.: Motivación para realizar el estudio: Existen pocos estudios acerca del Virus del Papiloma Humano (VPH) de alto riesgo en pacientes con cáncer de mama (CaMa), la cual es actualmente la neoplasia más recurrente en Perú. Principales hallazgos: Se evidenció mayor presencia del VPH en las biopsias de carcinoma ductal infiltrante y grado III, además, se demostró que la reacción en cadena de la polimerasa en tiempo real tuvo mayor precisión diagnóstica que la inmunohistoquímica. Implicancias: Un mejor entendimiento de la presencia de VPH y su posible relación con CaMa contribuirán en las medidas preventivas para esta enfermedad. El objetivo de este estudio fue determinar la presencia del Virus Papiloma Humano (VPH) tipo 16 y 18 en biopsias de tejido mamario parafinado de pacientes con diagnóstico clínico de cáncer de mama. Se analizaron 32 biopsias de cáncer de mama embebidas en parafina para detectar el ADN de VPH mediante PCR en tiempo real, los iniciadores estuvieron dirigidos al gen E6. Se evaluaron el tipo histológico, grado histológico y la sobreexpresión de C-erB2 y Ki-67 mediante inmunohistoquímica. El 84,38% (27) fueron positivos para VPH, el 25% (8) fueron positivos para VPH-16 y el 59,38% (19) para VPH-18. El 15,63% (5) de las muestras presentaron infección mixta. Se evidenció la sobrexpresión de C-erbB2 y Ki-67 en 6,25% (2) de las muestras positivas para VPH-16 y 15,63% (5) de las muestras positivas para VPH-18. Se detectó ADN de VPH-16 y VPH-18 en las muestras de biopsias analizadas mediante PCR en tiempo real.


Assuntos
Neoplasias da Mama , Infecções por Papillomavirus , Rosa , Humanos , Feminino , Neoplasias da Mama/patologia , Papillomavirus Humano , Rosa/genética , Infecções por Papillomavirus/diagnóstico , Imuno-Histoquímica , Estudos Transversais , Antígeno Ki-67/genética , Papillomavirus Humano 16/genética , Papillomaviridae/genética , Papillomavirus Humano 18/genética , Reação em Cadeia da Polimerase em Tempo Real , Biópsia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...